When the NFL releases the schedule for the upcoming regular season, it's a small form of torture. Sure, we get to see the roadmap for the upcoming year and all the great games we have in store for us, ...

After three days of marquee matchups being unveiled, the 2026 NFL regular season schedule has arrived with the league's full Thursday reveal. Week 1 -- and the season -- kicks off as usual with the ...

We don't have to wait any longer for the NFL Week 1 schedule. The complete schedule has been leaked for the opening week of the 2026 NFL season. According to reports, the season will open with the New ...

Abstract: In the last decade, 1-bit synthetic aperture radar (SAR) imaging has been proposed, which uses 1-bit quantized echo data for scene reconstruction, offering substantial reductions in system ...

Amazon.com AMZN1.73%increase; green up pointing triangle is launching a program that provides access to GLP-1 treatments through its One Medical primary care arm. The company said Tuesday the new ...

Abstract: To enhance the motion adaptability of wheel-legged robot in complex environments, a novel data-driven value iteration (VI) control algorithm based on adaptive dynamic programming (ADP) is ...

Amazon One Medical launched a GLP-1 program integrating obesity care with Amazon Pharmacy. Pricing for the popular weight loss drugs will begin at as low as $25 per month with insurance. Shares of ...

Bitcoin (BTC) has gone up 4.5% over the past week as renewed institutional demand helped stabilize prices. At the same time, derivatives data indicate a cooling in forced selling activity. Notably, ...

Provisional purchasing managers’ surveys for March in the U.S. and Europe in the week will provide a key gauge of how the ongoing war in the Middle East has impacted sentiment and business activity.

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...

In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...